H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 10.2% of adults in Durham have diagnosed diabetes — 1.8 points below the U.S. 12% figure. Census population 293,330. North Carolina Medicare wound biologics: Palmetto GBA (JM). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Durham clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Durham storefront.
361 HCT/P Compliant Tissue Products in Durham, NC for clinics & physicians. Exclusively 361 HCT/P complian… Compliance support & pricing — contact Hawk Medical.
Two files matter before you open a box of 361 hctp compliant products in Durham: (1) CDC PLACES (2023, crude) estimates 10.2% of adults in Durham have diagnosed diabetes — 1.8 points below the U.S. 12% figure. (2) North Carolina Part B wound biologics are reviewed by Palmetto GBA under JM, shared with SC, VA, WV. We help with the second file. We do not pretend to be a Durham storefront.
National 361 HCT/P Compliant Tissue Products notes (how the product actually works)10.7% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city of 250k–500k with 293,330 residents will still mix those payers. CDC PLACES (2023, crude) estimates 10.2% of adults in Durham have diagnosed diabetes — 1.8 points below the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
Named person, real rates, no fake address. Joe Bradley, founder, active practice owner. CDC PLACES (2023, crude) estimates 10.2% of adults in Durham have diagnosed diabetes — 1.8 points below the U.S. 12% figure. Adult arthritis here is 20.6% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Schema on this site does not publish a fabricated star rating for Durham.
CDC PLACES (2023, crude prevalence) estimates 10.2% of adults — 1.8 points below the U.S. 12% figure. Obesity is 36.8%; arthritis is 20.6%. That is place-level BRFSS modeling, not a clinic census and not a Durham trial.
A 510(k)-cleared device has a different regulatory file than a 361 HCT/P. Do not store, bill, or describe them as the same SKU family. Your SOP should split receiving and indication language.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a North Carolina compliance risk.
No. /kw pages explain distribution options. Protocol, privilege, and informed consent remain with the licensed North Carolina clinician.
Bring specialty, monthly joint / regenerative volume, and whether you bill JM FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 10.2% diabetes and 20.6% arthritis for Durham — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Durham, NC.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Durham is JM geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Durham — 1.8 points below the U.S. 12% figure. Planning input, not an outcomes claim.
North Carolina Part B wound biologics follow this contractor (siblings: SC, VA, WV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Durham. Useful for joint-program math; still needs a diagnosis and privileging.
No Durham storefront. Joe Bradley is an active practice owner. 361 hctp compliant products stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.